Anzeige
Mehr »
Login
Mittwoch, 15.01.2025 Börsentäglich über 12.000 News von 681 internationalen Medien
Löst diese riesige Entdeckung die Kupferkrise der KI? So ändert sich die Rechnung durch diesen Explorer!!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
51 Leser
Artikel bewerten:
(0)

American Overseas Group, Ltd.: Results of Operations for the Three Months Ended September 30, 2024 - American Overseas Group Limited Announces Net Income Of $3.4 Million For the Three Months Ended September 30, 2024

Finanznachrichten News

HAMILTON, Bermuda, Dec. 30, 2024 (GLOBE NEWSWIRE) -- American Overseas Group Limited (BSX: AORE.BH) (Pink Sheets: AOREF.PK) ("AOG" or the "Company") today reported consolidated net income available to common shareholders of $3.4 million, or $73.42 per diluted share, for the three months ended September 30, 2024. This compares to consolidated net income available to common shareholders of $4.3 million, or $91.11 per diluted share, for the three months ended September 30, 2023. Book value per weighted share at September 30, 2024 was $969.27, an increase from the book value per weighted share of $776.61 at September 30, 2023.

For the three months ended September 30, 2024, net earned property and casualty premiums increased $5.7 million from $8.0 million a year ago to $13.7 million.

Quarter to Date fee income increased $0.8 million from $4.2 million to $5.0 million and gross written premiums increased $59.7 million, moving from $172.9 million to $232.6 million. Direct written premiums were positively impacted by continued expansion of new programs, rate increases, and organic growth in existing programs. Quarter to Date Loss and loss adjustment expenses as a percentage of earned premium increased slightly from 57.3% to 57.4%.

For the three months ended September 30, 2024, operating expenses decreased $0.3 million from $2.8 million to $2.5 million.

As part of its ongoing capital management efforts, the Company will continue to redirect excess capital within the group to debt reduction unless other compelling opportunities present themselves.

Forward-Looking Statements

This release contains statements that may be considered "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, without limitation, the Company's expectations respecting the volatility of its insured portfolio, losses, loss reserves and loss development, the adequacy and availability of its liquidity and capital resources, its current run off strategy, its strategy for writing other reinsurance businesses and its expense reduction measures. These statements are based on current expectations and the current views of the economic and operating environment and are not guarantees of future performance. A number of risks and uncertainties, including economic competitive conditions, could cause actual results to differ materially from those projected in forward-looking statements. The Company's actual results could differ materially from those expressed or implied in the forward-looking statements.

Information About the Company

American Overseas Group Limited is an insurance holding company incorporated in Bermuda and a tax resident of the United Kingdom. Its operating subsidiaries provide specialty property/casualty insurance, reinsurance and insurance management services. More information can be found at www.aoreltd.com.

American Overseas Group Limited

info@aoreltd.com

American Overseas Group Limited
Consolidated Balance Sheets
(unaudited)
As at September 30, 2024 and December 31, 2023
(dollars in thousands)
September 30, 2024 December 31, 2023
Assets
Investments:
Fixed-maturity securities held as available for sale, at fair value$146,468 $132,600
Cash and cash equivalents 44,302 56,854
Restricted cash 1,710 964
Accrued investment income 1,069 972
Premiums receivable 212,160 174,350
Deferred insurance premiums 269,190 219,828
Reinsurance balances receivable, net 378,075 348,930
Deferred policy acquisition costs 10,505 9,152
Intangible assets 4,800 4,800
Goodwill 33,050 33,050
Other assets 4,562 3,720
Total Assets
$1,105,891 $985,220
Liabilities and Equity
Liabilities:
Loss and loss expense reserve$370,086 $332,573
Deferred commission income 7,567 6,878
Unearned premiums 283,249 230,123
Ceded premium payable 222,247 183,969
Payable to general agents 268 10,885
Funds withheld 128,210 136,471
Accounts payable and accrued liabilities 25,139 25,725
Notes payable 20,771 20,771
Non-owned interest in VIE 300 300
Interest payable 578 578
Deferred tax liability 1,941 648
Total Liabilities
1,060,356 948,921
Shareholders' Equity:
Common shares 4,698 4,698
Additional paid-in capital 189,179 189,179
Accumulated other comprehensive (loss) (2,505) (3,454)
Retained deficit (145,837) (154,124)
Total Shareholders' Equity
45,535 36,299
Total Liabilities and Equity
$1,105,891 $985,220
See Notes to September 30, 2024 Consolidated Financial Statements available on American Overseas Group Ltd. Website at www.aoreltd.com
American Overseas Group Limited
Consolidated Statements of Operations
(unaudited)
(dollars in thousands, except share and per share amounts)
Three months ended September 30, Nine months ended September 30,
2024
2023
2024
2023
Revenues
Net premiums earned$13,716 $7,987 $37,266 $20,104
Fee income 5,023 4,191 16,093 11,847
Net investment income 421 215 918 555
Net realized gains on investments 42 2,425 47 2,862
Other income 22 25 59 64
Total revenues 19,224 14,843 54,383 35,432
Expenses
Losses and loss adjustment expenses 7,877 4,574 22,207 12,416
Acquisition expenses 4,030 2,628 11,182 6,379
Operating expenses 2,462 2,775 8,680 8,351
Interest expense 578 586 1,734 1,653
Total expenses 14,947 10,563 43,803 28,799
Pre-tax net profit $ 4,277 $ 4,280 $ 10,580 $ 6,633
Income tax (expense) (828) - (2,293) -
Net profit available to common shareholders 3,449 4,280 8,287 6,633
Net profit per common share:
Basic$73.42 $91.11 $176.39 $141.19
Diluted 73.42 91.11 176.39 141.19
Weighted-average number of common shares outstanding:
Basic 46,979 46,979 46,979 46,979
Diluted 46,979 46,979 46,979 46,979
See Notes to September 30, 2024 Consolidated Financial Statements available on American Overseas Group Ltd. Website at www.aoreltd.com

© 2024 GlobeNewswire (Europe)
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.